This inventor holds 1 USPTO granted patent. Top assignee: Terragen Diversity, Inc.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Seow Kah Tong: Innovator in Antibiotic Biosynthesis
Introduction
Seow Kah Tong is a notable inventor based in Johor, Malaysia. He has made significant contributions to the field of biotechnology, particularly in the area of antibiotic biosynthesis. His innovative work has the potential to impact various medical applications.
Latest Patents
Seow Kah Tong holds a patent for a method for the isolation of biosynthesis genes for bioactive molecules. This patent involves the use of degenerate primers that hybridize with various classes of antibiotic biosynthesis genes. The process amplifies DNA fragments from soil and lichen extracts, leading to the discovery of novel antibiotic biosynthesis gene sequences. These sequences have the potential to serve as antibiotics, immunosuppressors, and antitumor agents. The method combines sample preparation with polymerase chain reaction amplification, utilizing a carefully selected primer set to target conserved regions of known antibiotic biosynthetic pathway genes.
Career Highlights
Seow Kah Tong is currently employed at Terragen Diversity, Inc. His work at the company focuses on advancing research in biotechnology and developing innovative solutions for antibiotic production. His expertise in the field has positioned him as a key figure in the ongoing search for new antibiotics.
Collaborations
Seow Kah Tong collaborates with talented individuals such as Barbara Waters and Vivian Miao. These partnerships enhance the research efforts at Terragen Diversity, Inc. and contribute to the advancement of antibiotic biosynthesis research.
Conclusion
Seow Kah Tong's contributions to antibiotic biosynthesis through his innovative patent highlight the importance of research in biotechnology. His work has the potential to lead to significant advancements in medical treatments and the development of new antibiotics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile